SEC Form N-PORT · 2026-04-30
LABU ETF Holdings
Direxion Daily S&P Biotech Bull 3X Shares reported 161 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-04-30
- SEC accession
- 0001193125-26-287439
- Series ID
- S000049373
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE | 7.899642% | 40,990,416.22 | 40,990,416.22 PA |
| GOLDMAN FINANCIAL | GOLDMAN FINANCIAL | 6.660368% | 34,559,954.16 | 34,559,954.16 PA |
| N/A | N/A | 2.780034% | 14,425,305.89 | 1 NC |
| GOLDMAN SACHS LIQ ES FD A | GOLDMAN SACHS LIQ ES FD A | 1.815881% | 9,422,418.66 | 9,422,418.66 PA |
| APLS | Apellis Pharmaceuticals Inc | 1.532992% | 7,954,537.5 | 194,250 NS |
| N/A | N/A | 1.520455% | 7,889,482.91 | 1 NC |
| RVMD | Revolution Medicines Inc | 1.353961% | 7,025,561.76 | 48,748 NS |
| TVTX | Travere Therapeutics Inc | 1.331787% | 6,910,502.04 | 164,067 NS |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.183266% | 6,139,841.84 | 83,558 NS |
| TWST | Twist Bioscience Corporation | 1.16703% | 6,055,595.35 | 103,603 NS |
| SMMT | Summit Therapeutics Inc. | 1.153243% | 5,984,056.62 | 278,847 NS |
| ALKS | Alkermes PLC | 1.135749% | 5,893,283.33 | 174,823 NS |
| TGTX | TG Therapeutics Inc | 1.12676% | 5,846,642.4 | 173,080 NS |
| MDGL | Madrigal Pharmaceuticals Inc | 1.121649% | 5,820,120.11 | 11,249 NS |
| N/A | N/A | 1.101713% | 5,716,673.63 | 1 NC |
| BEAM | Beam Therapeutics Inc. | 1.088103% | 5,646,050.82 | 186,154 NS |
| APGE | Apogee Therapeutics Inc. | 1.038438% | 5,388,347.34 | 65,006 NS |
| SRRK | Scholar Rock Holding Corp. | 1.009874% | 5,240,129.25 | 112,425 NS |
| PRAX UW | PRAXIS PRECISION MEDICINES INC | 1.004313% | 5,211,276.35 | 16,345 NS |
| EXEL | EXELIXIS INC | 0.99633% | 5,169,853.26 | 116,281 NS |
| MIRM | Mirum Pharmaceuticals Inc. | 0.992379% | 5,149,353.27 | 52,917 NS |
| N/A | N/A | 0.984621% | 5,109,095.76 | 1 NC |
| UTHR | United Therapeutics Corporation | 0.981522% | 5,093,013.9 | 8,914 NS |
| NTRA | Natera Inc. | 0.981197% | 5,091,327.36 | 24,696 NS |
| CELC | Celcuity Inc. | 0.980852% | 5,089,540.35 | 41,941 NS |
| CRSP | CRISPR Therapeutics AG | 0.980802% | 5,089,279.9 | 97,235 NS |
| KRYS | Krystal Biotech Inc | 0.962178% | 4,992,643.62 | 19,037 NS |
| PTGX | Protagonist Therapeutics Inc | 0.959794% | 4,980,269.37 | 50,321 NS |
| NBIX | NEUROCRINE BIOSCIENCES INC | 0.950966% | 4,934,464.92 | 37,476 NS |
| INCY | Incyte Corporation. | 0.941648% | 4,886,112.49 | 51,287 NS |
| CGON | CG Oncology Inc. | 0.941119% | 4,883,365.8 | 73,170 NS |
| CYTK | Cytokinetics Inc | 0.940608% | 4,880,719.09 | 76,297 NS |
| NUVL | NUVALENT INC | 0.937711% | 4,865,685.88 | 48,521 NS |
| IONS | Ionis Pharmaceuticals, Inc. | 0.935218% | 4,852,746.36 | 64,911 NS |
| BBIO | Bridgebio Pharma Inc | 0.931931% | 4,835,693.33 | 68,003 NS |
| PCVX | Vaxcyte Inc | 0.930905% | 4,830,369.12 | 84,388 NS |
| KYMR | Kymera Therapeutics Inc | 0.930441% | 4,827,961.71 | 59,553 NS |
| BIIB | Biogen Inc | 0.929603% | 4,823,611.52 | 25,484 NS |
| COGT | Cogent Biosciences Inc. | 0.928076% | 4,815,687.66 | 134,554 NS |
| PTCT | PTC Therapeutics, Inc. | 0.926932% | 4,809,755.68 | 73,928 NS |
| INSM | Insmed Inc | 0.915103% | 4,748,373.9 | 34,830 NS |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 0.903676% | 4,689,082.99 | 15,151 NS |
| ROIV | Roivant Sciences Ltd | 0.902383% | 4,682,372.13 | 164,121 NS |
| HALO | Halozyme Therapeutics Inc | 0.895883% | 4,648,644.18 | 73,023 NS |
| ARQT | Arcutis Biotherapeutics Inc. | 0.881523% | 4,574,131.02 | 196,991 NS |
| SYRE | Spyre Therapeutics Inc | 0.879099% | 4,561,551.5 | 61,270 NS |
| SLNO UR | Soleno Therapeutics Inc | 0.872367% | 4,526,621.18 | 85,699 NS |
| ABBV | AbbVie Inc. | 0.868348% | 4,505,765.04 | 21,322 NS |
| AMGN | Amgen Inc. | 0.857668% | 4,450,351.25 | 12,853 NS |
| REGN | REGENERON PHARMACEUTICALS INC | 0.853967% | 4,431,145.02 | 6,267 NS |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.847238% | 4,396,227.33 | 178,057 NS |
| ACAD | ACADIA PHARMACEUTICALS INC | 0.846022% | 4,389,917.9 | 195,542 NS |
| RYTM | Rhythm Pharmaceuticals Inc | 0.845603% | 4,387,744.8 | 53,930 NS |
| GILD | Gilead Sciences Inc. | 0.838538% | 4,351,084.2 | 33,255 NS |
| BMRN | Biomarin Pharmaceutical Inc. | 0.836198% | 4,338,946.35 | 80,485 NS |
| VKTX | Viking Therapeutics Inc. | 0.815762% | 4,232,903.26 | 135,757 NS |
| VRTX | VERTEX PHARMACEUTICALS INC | 0.812112% | 4,213,966.8 | 9,860 NS |
| IBRX | ImmunityBio Inc | 0.803252% | 4,167,991.1 | 587,041 NS |
| IMVT | Immunovant Inc | 0.769256% | 3,991,590.82 | 147,047 NS |
| MRNA | Moderna Inc | 0.767963% | 3,984,881.54 | 86,741 NS |
| VERA | Vera Therapeutics Inc. | 0.75186% | 3,901,324.77 | 109,557 NS |
| IMNM | Immunome Inc | 0.743366% | 3,857,246.3 | 168,145 NS |
| IRON | Disc Medicine Inc | 0.736891% | 3,823,649.1 | 57,978 NS |
| VCYT | Veracyte Inc | 0.711648% | 3,692,669.32 | 112,171 NS |
| SRPT | Sarepta Therapeutics Inc | 0.704683% | 3,656,526.48 | 175,121 NS |
| CPRX | Catalyst Pharmaceuticals Inc. | 0.704478% | 3,655,465.37 | 129,949 NS |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 0.673121% | 3,492,753.8 | 381,305 NS |
| DYN | Dyne Therapeutics Inc. | 0.666098% | 3,456,314.55 | 196,941 NS |
| KOD | Kodiak Sciences Inc | 0.644898% | 3,346,307.76 | 76,962 NS |
| RXRX | RECURSION PHARMACEUTICALS INC | 0.639185% | 3,316,666.04 | 958,574 NS |
| GRAL | GRAIL Inc | 0.626296% | 3,249,786.48 | 59,651 NS |
| N/A | N/A | 0.619295% | 3,213,458.15 | 1 NC |
| RCUS | Arcus Biosciences Inc. | 0.609015% | 3,160,113 | 123,926 NS |
| AGIO | Agios Pharmaceuticals Inc | 0.596732% | 3,096,380 | 110,585 NS |
| DNLI | Denali Therapeutics Inc | 0.585137% | 3,036,215.52 | 162,191 NS |
| N/A | N/A | 0.579494% | 3,006,936.29 | 1 NC |
| ORKA | Oruka Therapeutics Inc | 0.574503% | 2,981,034.16 | 43,576 NS |
| DNTH | Dianthus Therapeutics Inc | 0.568622% | 2,950,519 | 33,605 NS |
| NTLA | Intellia Therapeutics Inc | 0.558557% | 2,898,294.36 | 215,007 NS |
| ERAS | Erasca Inc | 0.556615% | 2,888,216.1 | 271,194 NS |
| ADMA | ADMA BIOLOGICS INC | 0.556411% | 2,887,158.5 | 281,674 NS |
| SNDX | Syndax Pharmaceuticals Inc. | 0.554416% | 2,876,806.06 | 134,242 NS |
| ARDX | Ardelyx Inc | 0.535531% | 2,778,813.03 | 438,991 NS |
| IDYA | IDEAYA Biosciences Inc. | 0.523239% | 2,715,030 | 93,300 NS |
| MLYS | Mineralys Therapeutics Inc. | 0.521588% | 2,706,467.4 | 101,556 NS |
| NRIX | Nurix Therapeutics Inc. | 0.517961% | 2,687,647.9 | 160,937 NS |
| TNGX | Tango Therapeutics Inc. | 0.47072% | 2,442,519.5 | 112,975 NS |
| CLDX | Celldex Therapeutics Inc. | 0.44367% | 2,302,158.96 | 70,017 NS |
| CAPR | CAPRICOR THERAPEUTICS INC | 0.43429% | 2,253,486.64 | 67,108 NS |
| VCEL | Vericel Corporation | 0.427899% | 2,220,323.63 | 63,931 NS |
| INBX | Inhibrx Biosciences Inc. | 0.42235% | 2,191,530.81 | 16,961 NS |
| GLUE | Monte Rosa Therapeutics Inc | 0.415592% | 2,156,462.35 | 112,609 NS |
| NVAX | Novavax Inc | 0.408368% | 2,118,978.58 | 267,379 NS |
| BHVN | Biohaven Ltd | 0.406895% | 2,111,334.4 | 220,160 NS |
| STOK | Stoke Therapeutics Inc | 0.40654% | 2,109,491.12 | 64,471 NS |
| RLAY | Relay Therapeutics Inc | 0.404908% | 2,101,023.36 | 162,116 NS |
| TSHA | Taysha Gene Therapies Inc. | 0.397509% | 2,062,634.49 | 322,791 NS |
| VRDN | Viridian Therapeutics Inc | 0.396991% | 2,059,946.2 | 152,815 NS |
| OLMA | Olema Pharmaceuticals Inc. | 0.393118% | 2,039,850.78 | 141,558 NS |
| PVLA | Palvella Therapeutics Inc. | 0.38838% | 2,015,265.6 | 15,705 NS |
| QURE | Uniqure N.V. | 0.373567% | 1,938,401.85 | 97,163 NS |
| ANAB | AnaptysBio Inc. | 0.371511% | 1,927,729.44 | 29,328 NS |
| CRVS | Corvus Pharmaceuticals Inc | 0.354804% | 1,841,043.19 | 121,201 NS |
| MNKD | MANNKIND CORP | 0.341374% | 1,771,356.43 | 625,921 NS |
| CDNA | Caredx Inc | 0.339857% | 1,763,481.02 | 84,742 NS |
| KALV | KALVISTA PHARMACEUTICALS INC | 0.316859% | 1,644,148.86 | 61,671 NS |
| IOVA | Iovance Biotherapeutics Inc | 0.301785% | 1,565,931.36 | 466,051 NS |
| VIR | VIR Biotechnology Inc | 0.284811% | 1,477,855.13 | 144,675 NS |
| GERN | GERON CORP | 0.282257% | 1,464,601.6 | 951,040 NS |
| PGEN | Precigen Inc | 0.275448% | 1,429,272 | 343,575 NS |
| SLS UR | SELLAS LIFE SCIENCES GROUP INC | 0.256105% | 1,328,901.75 | 268,465 NS |
| TYRA | Tyra Biosciences Inc | 0.251231% | 1,303,611.5 | 37,514 NS |
| ABSI | Absci Corp. | 0.248664% | 1,290,291.13 | 259,355 NS |
| ANNX | Annexon Inc | 0.247502% | 1,284,262.08 | 218,784 NS |
| KURA | Kura Oncology Inc. | 0.245719% | 1,275,007.85 | 144,395 NS |
| SANA | Sana Biotechnology Inc | 0.241298% | 1,252,072.01 | 380,569 NS |
| AVBP | ArriVent BioPharma Inc. | 0.240247% | 1,246,615.73 | 40,097 NS |
| ORIC | ORIC Pharmaceuticals Inc. | 0.23666% | 1,228,004.96 | 124,292 NS |
| RIGL UW | Rigel Pharmaceuticals Inc. | 0.225852% | 1,171,923.9 | 40,551 NS |
| JANX | Janux Therapeutics Inc | 0.225737% | 1,171,327.44 | 81,512 NS |
| CTMX | Cytomx Therapeutics Inc | 0.209931% | 1,089,308.6 | 258,130 NS |
| SVRA | Savara Inc | 0.20538% | 1,065,695.48 | 203,377 NS |
| SPRY | ARS Pharmaceuticals Inc | 0.201555% | 1,045,848.16 | 126,616 NS |
| ZBIO | ZENAS BIOPHARMA INC | 0.193044% | 1,001,684.04 | 51,847 NS |
| CGEM | Cullinan Therapeutics Inc | 0.188093% | 975,996.45 | 74,789 NS |
| XNCR | Xencor Inc | 0.187035% | 970,505.5 | 81,350 NS |
| IRWD | Ironwood Pharmaceuticals, Inc. | 0.185351% | 961,768.5 | 233,156 NS |
| SION | Sionna Therapeutics Inc. | 0.177707% | 922,104.9 | 23,827 NS |
| BCAX | Bicara Therapeutics Inc. | 0.170111% | 882,686.74 | 40,903 NS |
| PURR | HYPERLIQUID STRATEGIES INC | 0.165811% | 860,378.4 | 142,920 NS |
| PRME | Prime Medicine Inc | 0.158523% | 822,560.53 | 232,034 NS |
| VOR UW | VOR BIOPHARMA INC | 0.150119% | 778,950.14 | 54,358 NS |
| EBS | Emergent Biosolutions Inc | 0.145451% | 754,732.15 | 91,705 NS |
| RGNX | Regenxbio Inc. | 0.137464% | 713,285.43 | 79,519 NS |
| VNDA | VANDA PHARMACEUTICALS INC | 0.135943% | 705,392.1 | 99,351 NS |
| N/A | N/A | 0.133972% | 695,166.35 | 1 NC |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | 0.131524% | 682,462.56 | 29,328 NS |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 0.131364% | 681,632.89 | 76,847 NS |
| ALLO | ALLOGENE THERAPEUTICS INC | 0.124748% | 647,304.87 | 303,899 NS |
| ALT UQ | Altimmune Inc. | 0.124728% | 647,199.8 | 248,923 NS |
| VSTM | Verastem Inc | 0.123593% | 641,309.76 | 117,456 NS |
| PRTA | Prothena Corporation PLC | 0.122193% | 634,047.68 | 57,328 NS |
| LXEO | Lexeo Therapeutics Inc | 0.119187% | 618,448.53 | 108,595 NS |
| MYGN | Myriad Genetics Inc. | 0.115291% | 598,234 | 125,944 NS |
| ABUS | Arbutus Biopharma Corp. | 0.107034% | 555,387 | 132,235 NS |
| RCKT | ROCKET PHARMACEUTICALS INC | 0.101935% | 528,928.68 | 151,991 NS |
| OCGN | OCUGEN INC | 0.10152% | 526,778.08 | 304,496 NS |
| AVXL | Anavex Life Sciences Corp. | 0.099595% | 516,788.18 | 154,727 NS |
| AKBA | Akebia Therapeutics Inc. | 0.093636% | 485,869.02 | 352,079 NS |
| IVVD | Invivyd Inc | 0.088947% | 461,535.2 | 329,668 NS |
| MDXG | MiMedx Group Inc. | 0.086178% | 447,168.96 | 133,086 NS |
| CATX UA | PERSPECTIVE THERAPEUTICS INC | 0.075083% | 389,598.3 | 99,897 NS |
| CMPX | Compass Therapeutics Inc | 0.071914% | 373,154.94 | 210,822 NS |
| REPL | Replimune Group Inc | 0.06316% | 327,728.97 | 127,521 NS |
| DMRA | DAMORA THERAPEUTICS INC | 0.02706% | 140,411.52 | 5,472 NS |
| NOVOB DC CVR | NOVOB DC CVR | 0% | 0 | 128,720 NS |
| INHIBRX INC CVR | INHIBRX INC CVR | 0% | 0 | 164,173 NS |
| DREYFUS | DREYFUS | 0% | 0 | 0 PA |
| 2200963D | OMNIAB INC | 0% | 0 | 14,783 NS |
| 2200964D | OMNIAB INC | 0% | 0 | 14,783 NS |
| VERVE THERAPEUTICS INC (CVR) | VERVE THERAPEUTICS INC (CVR) | 0% | 0 | 82,531 NS |